Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming bina...
RBC Capital analyst Brian Abrahams initiates coverage on Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform rating and a...
Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and raises the price target ...
Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate o...
